An AI model built by researchers at the Massachusetts Institute of Technology helps robots better predict how they’ll interact with solid objects and liquids, improving their ability to mold deformable materials.

Switching both low-and high-income women from affordable to high-deductible health plans (HDHPs) resulted in lengthy delays in breast cancer diagnosis and treatment, reported authors of a large study published in Health Affairs.

High-deductible health plans (HDHPs) are associated with numerous delays in care for patients with breast cancer, according to new research published in Health Affairs.

Two studies published April 18 in the journal Cell have shined new light on the role genetics can play in developing obesity—or protecting against it.

America’s opioid crisis cost the federal government some $26 billion in lost tax revenue and state governments $11.8 billion in lost revenue between 2000 and 2016, according to a recent analysis.

Pairing an informative video with a brochure outlining the possible harms and benefits of low-dose CT lung cancer screening bolstered smoker’s and former smoker’s confidence in their decision to undergo screening, reported authors of a recent study published in the Annals of the American Thoracic Society.

Both low- and high-income women experience significant delays in breast cancer diagnosis and treatment when they’re switched from affordable to high-deductible health plans (HDHPs), according to a study published in Health Affairs.

The 71-year-old Framingham Heart Study has received $38 million from the National Heart, Lung, and Blood Institute to fund a new six-year study into the biology of aging.

Deep learning techniques can be used to detect catheters and tubes in pediatric x-rays, according to a new study published in the Journal of Digital Imaging. These findings could lead to advancements that prioritize x-rays with poorly placed catheters, bringing them to a specialist’s immediate attention.

The first study to test an experimental antiplatelet compound in humans found the therapy inhibited clot formation without increasing bleeding, suggesting it could avoid that dangerous side effect of other clot-preventing drugs.